Study of ATB-320 for people with advanced solid tumors
Part of Cancer clinical trials.
This trial tests an investigational drug called ATB-320 in people whose cancer has spread or not responded to standard treatments. The goal is to first check if it is safe and tolerable, and to understand how it might help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed solid tumor (a cancer that is not a blood cancer).
- Your cancer must have gotten worse after standard treatment, or you may not be able to take standard treatment.
- You need to be able to provide a tumor sample (from a stored sample or a new biopsy), and it must be safe to have additional biopsies during the study.
- You should be in generally good physical condition (able to do light activity or be fully active) with an ECOG score of 0 or 1.
- You must have an expected survival of at least 12 weeks (about 3 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug, BA1203, for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and whether it can help shrink tumors.
This trial tests an experimental drug called IBI3020 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective for these patients.
This trial is testing two new drugs (DB-1311 with BNT327 or DB-1305) in people with certain advanced or metastatic solid tumors that have not responded to prior treatments. It aims to see if the combination shrinks tumors or slows cancer growth.
This trial tests an experimental drug, BNT3214, in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if BNT3214 is safe and helps shrink tumors.
This trial tests a new drug, BTM-3566, for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective.
This trial tests an experimental drug called T320 for people with advanced solid tumors that have not improved with standard treatments. The drug targets a protein on tumor cells to deliver chemotherapy directly to the cancer, possibly slowing growth.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.